Shopping Cart
- Remove All
- Your shopping cart is currently empty
S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expression [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $130 | 5 days |
Description | S07-1066, an aldo-keto reductase 1C3 (AKR1C3) inhibitor, enhances doxorubicin (DOX) cytotoxicity by selectively inhibiting AKR1C3-mediated reduction of DOX and reversing DOX resistance in cells with elevated AKR1C3 expression [1]. |
Molecular Weight | 325.16 |
Formula | C16H11Cl2FO2 |
Cas No. | 876625-29-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.